ChemicalBook
English   Japanese   Germany   Korea

N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide

, 902255-20-3, 结构式
CAS号:
902255-20-3
英文名:
N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide
英文别名:
Acetamide, N-[3'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-2-oxospiro[3H-indole-3,2'(3'H)-[1,3,4]thiadiazole]-5'(1H)-yl]-;N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide
中文名:
中文别名:
CBNumber:
CB54020182
分子式:
C22H22N4O5S
分子量:
454.5
MOL File:
902255-20-3.mol

N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide化学性质

密度:
1.39±0.1 g/cm3(Predicted)
酸度系数(pKa):
8.79±0.20(Predicted)
安全信息

N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide性质、用途与生产工艺

N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide 上下游产品信息

上游原料

下游产品

N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide 生产厂家

全球有 4家供应商   N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide国内生产厂家
供应商联系电话电子邮件国家产品数优势度
Interbioscreen Ltd. screen@ibscreen.chg.ru 芬兰 6178 60
SPECS info@specs.net 荷兰 6835 70
OTAVA-BB north.america@otavachemicals.com 乌克兰 6495 72
PHARMEKS Ltd. sales@pharmeks.com 芬兰 6350 50
 

902255-20-3, N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide 相关搜索:

  • 902255-20-3
  • Acetamide, N-[3'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-2-oxospiro[3H-indole-3,2'(3'H)-[1,3,4]thiadiazole]-5'(1H)-yl]-
  • N-{4'-acetyl-1-[2-(2-methoxyphenoxy)ethyl]-1,2,4',5'-tetrahydro-2-oxospiro(indole-3,5'-[1,3,4]thiadiazol)-2'-yl}acetamide
Copyright 2016 © ChemicalBook. All rights reserved